Renee Compton Ryan

EIR Expert at DigitalDx Ventures

San Francisco Bay Area

Overview

Renee Compton Ryan is a highly accomplished executive in the healthcare and healthtech industries, currently serving as the Chief Executive Officer and Board Member at Cala Health. With a background in investment banking and venture capital, Renee has founded companies like Verb Surgical Inc. and held leadership roles at prominent organizations such as Johnson & Johnson, showcasing expertise in corporate development, business strategy, and commercialization. Notable highlights of Renee's career include founding Verb Surgical Inc. and leading Cala Health as CEO and Board Member, demonstrating a strong track record in entrepreneurship and executive management within the healthcare sector.

Work Experience

PinPrint

Co-Founder & CEO
2024 - Current
Our amazing founding team at PinPrint is dedicated to transforming the patient experience with vaccinations and drug therapies by enhancing patient comfort and driving improved health outcomes.

RefleXion Medical

Independent Director, Audit Committee
2021

RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.

Raised $675,100,000.00 from Catalio Capital Management, T. Rowe Price, Venrock, The Rise Fund, Squarepoint Capital, Pictet Private Equity Investors S.A., Pfizer Venture Investments, Ally Bridge Group, Hillenbrand Capital Partners, LLC. and Johnson & Johnson Innovation – JJDC.

reflexion.com

NeuroPace

Board Member (Audit and Compensation Committees)
2013

NeuroPace develops and markets implantable devices for the treatment of neurological disorders.

Raised $307,300,000.00 from National Institutes of Health.

neuropace.com

DigitalDx Ventures

EIR Expert
2023

DigitalDx Ventures is a Venture firm.

digitaldxventures.com

Cala Health

Chief Executive Officer and Member of the Board of Directors
2019 - 2023

Cala Health is a bioelectronic medicine company that provides medical devices and neurotherapeutics for managing chronic health conditions.

Raised $198,300,000.00 from Johnson & Johnson Innovation – JJDC, Lightstone Ventures, Nexus NeuroTech, Reimagined Ventures, Fiscus Ventures, Lux Capital, Action Potential Venture Capital, Ascension Ventures, OSF Ventures and Google Ventures.

calahealth.com